InvestorsHub Logo
Followers 69
Posts 6650
Boards Moderated 0
Alias Born 02/10/2010

Re: chsmoke post# 267194

Monday, 06/07/2021 7:43:33 PM

Monday, June 07, 2021 7:43:33 PM

Post# of 333515
Everyone is entitled to an opinion


IMO, the previous CEO was a 'my way or the highway' kind of guy. This caused lost opportunities for BIEL.

Starting in 2020 that attitude was gone.

Dr. Staelin, a respected Professor of Marketing, brought back to the BOD as Chairman.

Keith Nalepka, 15 years experience selling Medical Products, appointed to the BOD.

The realization that BIEL does not have the resources to Educate and Market to 320 million Americans, followed by the switch to a OEM Business Plan.

BIEL achieves an 18 year goal of FDA Clearance for a Full Body OTC ActiPatch.

OEM Agreements reached with 3 companies, that we know of probably more, to market ActiPatch Enhanced Products in the US.

This is an amazing turnaround, especially when one understands that it was accomplished during the worst Global Pandemic in the last 100 years, Trillions of dollars lost to business disruptions around the world .